<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate the outcomes of treatment in patients suffering from recurrent <z:hpo ids='HP_0005268'>spontaneous abortion</z:hpo> and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: 148 observed women suffering from <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent abortion</z:e> with presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> antibodies (LA) and/or high moderate concentration of anticardiolipin antibodies (ACA) have been divided randomly into followed three treated groups: I--56 patients treated by low-dose of <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> (LDA, 75 mg daily); II--39 patients treated by low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> (applied in dose of 20 g daily); III--53 patients treated by LDA and low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> simultaneously </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: It has been affirmed that coincidental application of low-dose of <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> and low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> statistically more often increase the percentage of successful pregnancy in comparison with application of low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> or <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> alone </plain></SENT>
<SENT sid="3" pm="."><plain>In the group where only low-dose of <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> was applied the success of pregnancy equaled 89.3%, in the group where only low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> was applied the successful pregnancy equaled 81.1% and in the group with <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> and low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> being applied together the successful pregnancy equaled 92.5% </plain></SENT>
<SENT sid="4" pm="."><plain>In has simultaneously been affirmed that the percentage of pregnancy loss is statistically higher in the women suffering from isolated occurrence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> antibodies (21.2%) in comparison with the women suffering from occurrence of anticardiolipin antibodies (6.7%) and anticardiolipin antibodies with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> antibodies simultaneously </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: 1 </plain></SENT>
<SENT sid="6" pm="."><plain>Simultaneous application of low-doses of <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> and low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> seems to be the best solution in patients suffering from recurrent <z:hpo ids='HP_0005268'>spontaneous abortion</z:hpo> and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>2 </plain></SENT>
<SENT sid="8" pm="."><plain>The occurrence of anticardiolipin antibodies in the serum of blood in patients suffering from <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> is a better foretelling factor for the future pregnancy outcome than the occurrence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> antibodies </plain></SENT>
</text></document>